title: Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy (HCM): but what about 'apical' HCM?
authors.affiliation: NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol, UK.
authors.forename: Amardeep Ghosh
authors.initials: AG
authors.lastname: Dastidar
authors.affiliation: NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol, UK.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Rodrigues
authors.affiliation: NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol, UK.
authors.forename: Chiara
authors.initials: C
authors.lastname: Bucciarelli-Ducci
mesh_terms: D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis*; D003287:Contrast Media; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009206:Myocardium / Q000473:pathology*; D009942:Organometallic Compounds
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; C090600:gadobutrol; D019786:Gadolinium DTPA